1 min read
Add as a preferred source on Google

Sanofi Selects Jacobs as EPCM Partner for Frankfurt Insulin Plant

The facility will sit alongside Sanofi’s existing insulin manufacturing campus in Frankfurt, Germany, and support production of multiple types of insulin.

Steel framing rises beside a modern pharmaceutical production building / TokenPost.ai
Steel framing rises beside a modern pharmaceutical production building / TokenPost.ai

Sanofi selected Jacobs as the engineering, procurement and construction management partner for a new insulin manufacturing facility in Frankfurt, Germany, expanding development at the company’s existing insulin campus.

The planned plant will sit alongside Sanofi’s established manufacturing campus and support production of multiple types of insulin.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…